A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects
PHASE1
GSK2269557 is potent and highly selective inhaled phosphoinositides 3-kinas...
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
PHASE3
A study to test for non-inferiority of preprandial HIIP \[also known as AIR...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.